Publications by authors named "Laura E M Eurelings"
Am J Ophthalmol
August 2022
Article Synopsis
- This study evaluated how effective adalimumab is for treating noninfectious uveitis and explored why some patients stop using it, including its side effects.
- The analysis included 341 patients from two eye care centers in Rotterdam between 2004 and 2020, focusing on outcomes like achieving inactive disease and reasons for treatment discontinuation.
- Results indicated that adalimumab was effective, with 178 patients reaching inactive disease, and while some experienced relapses, many maintained remission even after stopping the drug, suggesting it has a manageable side effect profile.
Article Synopsis
- The soluble interleukin 2 receptor (sIL-2R) is being studied as a potential diagnostic marker for sarcoidosis, but its effectiveness in distinguishing sarcoidosis from other diseases has not been previously evaluated.
- A cohort study analyzed serum sIL-2R levels in patients suspected of having sarcoidosis, comparing it with angiotensin-converting enzyme (ACE) levels, a current diagnostic standard.
- The results demonstrated that sIL-2R has a higher sensitivity (88%) and specificity (85%) for diagnosing sarcoidosis compared to ACE, which has a sensitivity of 62% and specificity of 76%, indicating that sIL-2R could be a more reliable marker for this disease.
